ContactTeam
IGES Pharma provides solutions for your market access challenges. We consider our broad experience as a toolbox at your service. Depending on your needs and specifications, tailored solutions are put together from one source, integrating expertise and experts from our subsidiaries in Europe as needed.
Janice Acker
Value & Access Strategy
Dr. Manuela Bamberger
Value & Access Strategy
Adam Ben Taieb
Market Access UK
Fabian Berkemeier
Managing Director Pharma & Biotech
Wiebke Braunschweig
Statistics & Biometrics
Susanne Brückel
HTA & Value Demonstration
Veronika Deák
Value & Access Strategy
Dr. Katrin Domes-Martin
HTA & Value Demonstration
Alice Elisabeth doe Reis Dias Heller
HTA & Value Demonstration
Undine Euker
HTA & Value Demonstration
Dr. Norbert Gerbsch
Public Affairs
Peter Gray
Statistics & Biometrics
Donald Lorenz Gujer
HTA & Value Demonstration
Prof. Dr. Bertram Häussler
Chairman of the Board of Management Health Services Research
Stefan Hargesheimer
Value & Access Strategy
Carl-Christoph Henkel
Clinical Research
Dr. Jana Heppt
HTA & Value Demonstration
Juna Hertlein
Value & Access Strategy
Dr. Ariane Höer
Pharmaceutical Market Research
Wioletta Kotowa
Authorized Signatory Pharma & Biotech
Heidi Kulas
Statistics & Biometrics
Dr. Marc Kurepkat
CEO Clinical Research
Julia Isabella Krieger
Value & Access Strategy
Florentine Lang
HTA & Value Demonstration
Hong Anh Le
Value & Access Strategy
Lukas Maag
Pharmaceutical Market Research
Dr. Tilo Mandry
International Liaison Manager
Karina Manz
Value & Access Strategy
Jörg Mathes
HTA & Value Demonstration
Dr. Ann-Katrin Menzner
HTA & Value Demonstration
Tatjana Meyer
HTA & Value Demonstration
Pierre Moïse
Managing Director IFPC
Santoke Naal
Managing Director IUPC
Rohan Naal
Market Access UK
Corinne Perret
HTA & Value Demonstration
Stefan Reindl
HTA & Value Demonstration
Dr. Stephan Ruckdäschel
Managing Director HealthEcon (CH)
Guido Schiffhorst
Director of Statistics & Biometrics
Evelyn Elisabeth Schlegl-Zanetti
HTA & Value Demonstration
Dr. Hans-Jürgen Seitz
HTA & Value Demonstration
Stephanie Sussmann
Value & Access Strategy
Thanh Thao Tran
Value & Access Strategy
Eveline van Eerd
HTA & Value Demonstration
Valeria Weber
Value & Access Strategy
Lara Luisa Wolff
Value & Access Strategy
Martha Wolfram
Value & Access Strategy
Johannes Ziemen
HTA & Value Demonstration
Further Team Members
- Dr. Amir Ansaripour | Health Economics & Outcomes Research
- Eika Louisa Bergemann | HTA & Value Demonstration
- Dr. Jolantha Beyerle | HTA & Value Demonstration
- Matt Bonnington | Market Access UK
- Gamze Fackelmann | Health Economics & Outcomes Research
- Nikola Göttler | HTA & Value Demonstration
- Dr. Pascale Holzerny | HTA & Value Demonstration
- Dr. Mehdi Javanbakht | Health Economics & Outcomes Research
- Vasileios Kontogiannis | Health Economics & Outcomes Research
- Sylvia Krüger | Clinical Research
- Patrick Lambert | Clinical Research
- Dr. Jana Maresch | HTA & Value Demonstration
- Atefeh Mashayekhi | Health Economics & Outcomes Research
- Eoin Moloney | Health Economics & Outcomes Research
- Dr. Barbara Obertreis | HTA & Value Demonstration
- Maciej Rowinski | Statistics & Biometrics
- Sakshi Sharma | Health Economics & Outcomes Research
- Dr. David Steinl | HTA & Value Demonstration
- Dr. Silvia Uecker | Clinical Research
- Dr. Elke Ziegler | HTA & Value Demonstration
